Download to read offline
Value to strategic partners
- 1. Diabetic Nephropathy Diabetic Retinopathy Hypercholesterolemia OralMucositis Gout Acute Lymphocytic Leukemia Bone Metastasis Brain Cancer Breast Cancer Cervical Cancer Chronic Lymphocytic Leukemia Endometrial Cancer Ewing Sarcoma Gastric Cancer Gastrointestinal Stromal Tumors Head And Neck Cancer Hodgkin Lymphoma Kidney Cancer Liver Cancer Malignant Mesothelioma Medullary Thyroid Cancer Melanoma Multiple Myeloma Non-Hodgkin Lymphoma Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Testicular Cancer Thyroid Cancer Age Related Macular Degeneration Keratoconjunctivitis sicca (Dry Eye) Retinal Vein Occlusion Acute Respiratory Distress Syndrome Sepsis Staphylococcal Infections Acute Coronary Syndrome Angina Pectoris Atrial Fibrillation Coronary Artery Disease (CAD) Critical Limb Ischemia Hypertension Pulmonary Arterial Hypertension Acute Pain Anxiety Disorders Chronic Pain Dementia Diabetic Neuropathy Obsessive-Compulsive Disorder Osteoarthritis Pain Parkinson's Disease Post-Traumatic Stress Disorder Restless Legs Syndrome Schizophrenia Traumatic Brain Injury Liver Cirrhosis Childhood Enuresis Growth Hormone Disorders Hyperparathyroidism Hyperthyroidism Guillain-Barre Syndrome Cytomegalovirus Fungal Infections Gram-Negative Bacterial Infections H1N1 Infection Herpes Zoster HIV-1 Infection Human Papillomavirus Infections Staphylococcus Aureus (MRSA) Cardiovascular Devices Prosthetic Heart Valve Peripheral Vascular Devices Cardiovascular Monitoring & Diagnostic Devices Cardiovascular Surgery Cardiac Rhythm Management Cardiovascular Prosthetic Devices Interventional Cardiology Cardiac Assist Devices Wound Care Management Hospital Supplies Syringes and Needles Disposable Hospital & Surgical Supplies Drug Delivery Devices Inhalation Systems Needle Free Injections Infusion Systems Diabetes Care Devices Insulin Delivery & Glucose Monitoring Ophthalmic Devices Cataract Surgery Devices Ophthalmic Diagnostic Equipment Refractive Surgery Devices ENT Devices Hearing Implants Diagnostic Devices Electrosurgical Devices Dental Equipment & Accessories Diagnostic Imaging & MRI Systems C/T Systems & Mammography Equipment X-Ray & Ultrasound Systems Nuclear Imaging Equipment Contrast Media Injectors Bone Densitometry Anesthesia and Respiratory Devices Anesthesia Machines & Disposables Respiratory Devices & Disposables Sleep Apnea Diagnostic Systems Healthcare IT Medical Imaging Information Systems Nephrology and Urology Devices Renal Dialysis Equipment Orthopedic Devices Orthobiologics & Arthroscopy Joint Reconstruction Trauma Fixation Orthopedic Prosthetics Cranium Maxillofacial Fixation (CMF) Spinal Surgery Endoscopy Devices & instruments Rigid & Flexible Endoscope In Vitro Diagnostics Genetic Testing Clinical Chemistry Hematology Immuno Chemistry Infectious Immunology Histology And Cytology Patient Monitoring Multiparameter Patient Monitoring Micro-Electromechanical Systems Non-invasive Blood Pressure Monitors Neurology Devices Neurostimulation Devices Interventional Neurology CSF Management Neurosurgical Products Radiosurgery Value to the Strategic Partner
- 2. Healthcare’s Investment Bank 2015:Global Healthcare Capital Markets S T R A T E G I C P A R T N E R I N G P A T H W A Y
- 3. Healthcare’s Investment Bank HealthiosXchangefor Strategic Partners PHASE 1: Sector Development PHASE 2: Positioning PHASE 3: Engagement PHASE 5: Growth PHASE 4: Relationship PHASE 4: Data Analytics S T R A T E G I C P A R T N E R I N G P A T H W A Y
- 4. Healthcare’s Investment Bank PHASE1: Sector Development Selecting Sectors. Assembling EcoSystems. Aggregating Content. PHASE 2: Positioning Establishing Thought Leadership, Strategic Priorities & Process PHASE 3: Engagement Building Dialogue with Broad Universe of Targets PHASE 4: Relationship Solidifying Commitments with Priority Opportunities PHASE 4: BIG Data Trending. Predictions. Sentiment Analysis. Opinion Marking. PHASE 5: Growth Taking Action. HealthiosXchange for Strategic Partners
- 5. Healthcare’s Investment Bank HealthiosXchangefor Strategic Partners PHASE 1: Sector Development Selection & Segmentation Assembling EcoSystems Company Listings Presentations & O/M Clinical / Market Data Tagging PHASE 2: Positioning Strategic Page Communities & Groups Clinical & Market Research Sector Pages Xchange “LifeLines” Integrated Social Media PHASE 3: Engagement Custom Content Notifications Private / Public Valuations “Xchange Live” Hosted Chat Ratings & Reviews Expert Opinion WebCasts PHASE 5: Growth Opportunity Origination Site Visits Due Diligence LOI PHASE 4: Relationship Targeting & Tracking Messaging & Alerts “Grand Rounds” WebCast “Shark Tank” Xchange Conferences PHASE 4: BIG Data 18 million Data Points 3,000 Concurrent Experiments Trending & Activity Scores Milestones & Inflection Points Sentiment & Prediction
- 6. Healthcare’s Investment Bank PHASE1: Sector Development Segmentation & Selection Assembling EcoSystems Company Listings Presentations & O/M Clinical / Market Data Tagging
- 7. Healthcare’s Investment Bank PHASE2: Positioning Strategic Page Communities & Groups Clinical & Market Research Sector Pages Xchange “LifeLines” Integrated Social Media
- 8. Healthcare’s Investment Bank Phase3: Engagement Custom Content Notifications Private / Public Valuations Matching & GeoLocation Ratings & Reviews WebCasts & Chat
- 9. Healthcare’s Investment Bank Phase4: Relationships Targeting & Tracking Messaging & Alerts “Grand Rounds” WebCast “Shark Tank” Xchange Conferences
- 10. Healthcare’s Investment Bank Phase5: BIG Data Merger and acquisition prediction. Note that confidence is a bit smaller than 1. The actual number of months before the next transaction is 4. We predicted 3. The actual number of months before the next transaction is 11. We predicted 10. The actual value of the next transaction is $150 million and we predicted $150 million. The actual value of the next transaction is $21.65 million and we predicted $21.65 million. Target/Issuer Noveko International Inc. Sector Diagnostic Imaging State Quebec Country Canada T1_Type Private Placement T1_Total_Value 2.41 Months from T1 and T2 13 T2_Type Private Placement T2_Total_Value 2.68 Months from T2 and T3 8 T3_Type Private Placement T3_Total_Value 1.89 Next Transaction value (ORIGINAL) 21.65 Next Transaction value (PREDICTED) 21.65 Prediction confidence 0.9106 Type of event? When is it going to happen? How big will it be?18 million Data Points 3,000 Concurrent Experiments Trending & Activity Scores Milestones & Inflection Points Sentiment & Prediction
- 11. Healthcare’s Investment Bank Phase6: Growth Opportunity Origination Site Visits Due Diligence LOI $259,000,000 Completed a strategic partnership with THE UNDERSIGNED ACTED AS EXCLUSIVE FINANCIAL ADVISOR TO INSPIRATION INSPIRATION BIOPHARMACEUTICALS, INC.
- 12. Healthcare’s Investment Bank HealthiosXchangefor Strategic Partners PHASE 1: Sector Development Company Profile Selection & Segmentation Assembling EcoSystems Company Listings Presentations & O/M Clinical / Market Data Tagging PHASE 2: Positioning Strategic Profile Strategic Page Communities & Groups Clinical & Market Research Sector Pages Xchange Timeline Integrated Social Media PHASE 3: Engagement Going Social Xchange “LifeLines” Notifications Private / Public Valuations “Xchange Live” Hosted Chat Ratings & Reviews Expert Opinion WebCasts PHASE 5: Growth Close Deal Selection Site Visits Due Diligence LOI PHASE 4: Relationship Deal Selection Targeting & Tracking Messaging & Alerts “Grand Rounds” WebCast “Shark Tank” Xchange Conferences PHASE 4: Data Analytics Taking Action 18 million Data Points 3,000 Concurrent Experiments Trending & Activity Scores Milestones & Inflection Points Sentiment & Prediction
Editor's Notes
- #3 Today – more than ever before – the global healthcare industry is governed by strategic activity. In fact, the long-term success of strategic buyers and healthcare investors, alike, is inextricably tied to mergers, acquisitions and partnerships. For years, the priorities of strategic buyers throughout the global healthcare industry have emphasized marketing, sales and distribution as the principal drivers of shareholder value. This emphasis has fostered an intense dependence on M&A in order to sustain growth. In fact, although the dependence of strategic buyers on M&A is only accelerating, the competition for the best assets is intensifying. The best deals are increasingly difficult to secure…
- #4 In 2014, (2,017) M&A and partnering transactions were competed by 716 strategic partners. Since 2007, (2,052) strategic partners have consummated at least one transaction. HealthiosXchange understands that strategic activity is vital to vibrant, dynamic and efficient capital markets. In recognition of the importance of mergers, acquisitions and partnerships as the foundation of the global healthcare capital markets, the HealthiosXchange has been designed to assist the most important strategic partners in the world in achieving their own growth objectives and competitive priorities. For strategic partners, the HealthiosXchange is: The most dynamic business development experience serving the global healthcare industry A virtual expression of their distinct competitive advantages A data-centric platform which mimics the development and strategic pathway A highly efficient social medium involving all the market participants critical to success
- #5 In 2014, 7 of the top 10 M&A deals were in healthcare HealthiosXchange is the premier capital marketplace dedicated exclusively to the global healthcare industry. In positioning 2,000 strategic partners at the center of 6,000 emerging growth companies in (46) market sectors and (37) countries, HealthiosXchange has developed a revolutionary business development asset to support the competitive priorities of the most important strategic partners in the world.
- #6 92% of the market capitalization of the top 25 healthcare companies is trading at (or above) their all-time highs The HealthiosXchange for strategic partners involves a six-step routine, leveraging the most advanced technologies to permit access to data, relationships and opportunities in a infinitely scalable – yet completely customized – manner: SECTOR DEVELOPMENT: Developing an Xchange presence POSITIONING: Establishing Thought Leadership ENGAGEMENT: Shaping the message with a broad audience RELATIONSHIPS: Solidifying commitments with priority opportunities DATA ANALYTICS: Applying proprietary informatics to optimize decision-making GROWTH: Taking Action
- #7 At 17.2x, the Price/Earnings ratio of the S&P Healthcare index is at its highest point since 2002 PHASE 1 allows every strategic sponsor to organize their unique HealthiosXchange experience: Sectors are selected according to market presence EcoSystems consisting of Emerging Growth companies, investors, and key relationships are assembled according sector preferences Listings are established for every Emerging Growth Company in a designated sector Non-confidential Company information is gathered into each Company profile, along with preference data to enable transactions EcoSystem participants are “tagged” in order to enable data analytics (e.g. activity mapping, trending, geolocation, matching, targeting, alerts, notifications, prediction and sentiment analytics)
- #8 The 3-year organic revenue growth rate of the top-25 healthcare companies is 6.1% PHASE 2 enables strategic sponsors to establish a leadership presence within their selected market EcoSystems: Strategic sponsors will populate their own Xchange profile Xchange Groups will be assembled, containing members of sector EcoSystems designated for “Friending” and “Following” Research, opinion analysis, position papers will be posted to the Xchange which will inform the EcoSystems of priorities, perspectives and strategies of each strategic sponsor Sector Pages will assemble the Xchange listings of all EcoSystem participants Xchange “LifeLines” comprised real-time news feeds, customized by each Strategic sponsor, and targeted for each EcoSystem Each Xchange EcoSystem will be mapped to prevailing social medial networks
- #9 The market’s own growth expectation – as implied by the forward-year P/E ratio – is 13.1% PHASE 3 empowers strategic sponsors to establish their “Voice” with a broad audience of EcoSystem participa: Xchange LifeLines provides a constant “news feed” for the distribution of custom content Notifications allows strategic sponsors to be informed on the achievement of milestones, inflection points and catalysts Data on public and private transactions in selected market EcoSystems enables informed dialogue with target companies Exclusive targeting capabilities allows strategic sponsors to prioritize conversations among companies Proprietary Ratings & Review capabilities provides the market sentiment on a universe of companies in selected EcoSystems Integrated broadcasting capabilities enable communications with a broad audience of companies in an anonymous fashion
- #10 The number of strategic partnerships has increased 30% annually since 2010 PHASE 4 assists strategic sponsors in solidifying relationships with priority targets within a designated EcoSystem. The principal elements of Step #4 are Targeting and tracking specific transactions Secure messaging with management & Board “Grand Rounds” events, featuring many strategic sponsors hosting virtual conferences with many companies in a highly dynamic and efficient environment “Shark Tank” events, featuring one strategic sponsor presiding over a virtual presentation by many companies Live conference events (e.g. Incubator Days, Clinical Meetings, Investor Conferences) involving key participants from strategic sponsors and the management and Board of companies in selected sectors
- #11 Since 2002, 100% of the returns realized from emerging growth healthcare investments were generated by 23.6% of Companies PHASE 5 provides strategic sponsors with real-time data to measure the success of the Xchange process, reporting on activity within designated EcoSystems, and disseminating performance scores of target opportunities: Continuous analytics on 18 million data-points emanating from the activities of (6,000) companies , (30,000) investors, and (2,000) strategic buyers throughout the global healthcare industry 3,000 concurrent data experiments generating proprietary insights in key market categories Real-time trending and activity scores Benchmarking of key milestones and inflection points against 25-year historical and precedent data Exclusive sentiment analysis and event prediction
- #12 Since 2002, 100% of the returns realized from emerging growth healthcare investments were generated by 14.2% of the invested capital. PHASE 6 supports strategic sponsors in selecting opportunities, organizing the process and consummating the transaction.
- #13 HealthiosXchange is the premier capital marketplace dedicated exclusively to the global healthcare industry. In positioning 2,000 strategic partners at the center of 6,000 emerging growth companies in (46) market sectors and (37) countries, HealthiosXchange has developed a revolutionary business development asset to support the competitive priorities of the most important strategic partners in the world.